Adjuvants, Immunologic
/ administration & dosage
Animals
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Drug Carriers
/ chemistry
Drug Compounding
/ methods
Female
Hepacivirus
/ immunology
Hepatitis C
/ immunology
Hepatitis C Antigens
/ administration & dosage
Humans
Immunogenicity, Vaccine
Mice
Models, Animal
Organophosphorus Compounds
/ administration & dosage
Polymers
/ administration & dosage
Recombinant Proteins
/ administration & dosage
Structure-Activity Relationship
Vaccines, Subunit
/ administration & dosage
Viral Envelope Proteins
/ administration & dosage
Viral Hepatitis Vaccines
/ administration & dosage
complexation
hepatitis C virus
immunoadjuvants
polyphosphazenes
self-assembly
vaccine delivery
vaccines
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
13
6
2020
medline:
12
10
2021
entrez:
13
6
2020
Statut:
ppublish
Résumé
Two well-defined synthetic polyphosphazene immunoadjuvants, PCPP and PCEP, were studied for their ability to potentiate the immune response to the hepatitis C virus (HCV) E2 glycoprotein antigen
Identifiants
pubmed: 32530637
doi: 10.1021/acs.molpharmaceut.0c00487
pmc: PMC7755742
mid: NIHMS1604203
doi:
Substances chimiques
Adjuvants, Immunologic
0
Antibodies, Neutralizing
0
Antibodies, Viral
0
Drug Carriers
0
Hepatitis C Antigens
0
Organophosphorus Compounds
0
Polymers
0
Recombinant Proteins
0
Vaccines, Subunit
0
Viral Envelope Proteins
0
Viral Hepatitis Vaccines
0
poly(phosphazene)
0
glycoprotein E2, Hepatitis C virus
157184-61-7
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
726-734Subventions
Organisme : NIAID NIH HHS
ID : R01 AI132213
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI168048
Pays : United States
Références
Curr Opin Pediatr. 2020 Feb;32(1):125-138
pubmed: 31904601
Vaccine. 2007 Jan 26;25(7):1204-13
pubmed: 17140708
Biomacromolecules. 2017 Jun 12;18(6):2000-2011
pubmed: 28525259
Heliyon. 2016 Apr 22;2(4):e00102
pubmed: 27441274
Semin Immunol. 2013 Apr;25(2):130-45
pubmed: 23850011
Mol Pharm. 2017 Jul 3;14(7):2285-2293
pubmed: 28544850
Drug Des Devel Ther. 2016 Dec 15;10:4101-4110
pubmed: 28008233
Curr Opin Immunol. 2015 Aug;35:137-43
pubmed: 26241306
Cell Tissue Res. 2018 Dec;374(3):465-471
pubmed: 30294754
Nat Rev Immunol. 2014 Jul;14(7):505-14
pubmed: 24925139
Biomaterials. 2014 Oct;35(31):8876-8886
pubmed: 25023392
Front Immunol. 2015 Jul 20;6:367
pubmed: 26257735
J Virol. 2004 Sep;78(17):9224-32
pubmed: 15308717
Expert Rev Vaccines. 2007 Oct;6(5):835-47
pubmed: 17931162
Semin Immunol. 2018 Oct;39:14-21
pubmed: 29801750
Antiviral Res. 2002 Aug;55(2):227-78
pubmed: 12103428
Biomacromolecules. 2010 Aug 9;11(8):2033-8
pubmed: 20690712
Biomaterials. 1998 Jan-Feb;19(1-3):109-15
pubmed: 9678857
Curr Opin Virol. 2016 Oct;20:55-63
pubmed: 27657659
Vaccine. 2009 Mar 23;27(14):2055-64
pubmed: 19428830
Vaccine. 2015 Mar 10;33(11):1338-44
pubmed: 25637860
J Virol. 2005 Nov;79(21):13199-208
pubmed: 16227243
J Control Release. 2018 Oct 10;287:67-77
pubmed: 30110615
Front Immunol. 2013 Jan 10;3:406
pubmed: 23335921
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):48-55
pubmed: 17909315
Vaccine. 2008 May 23;26(22):2680-8
pubmed: 18430493
J Virol. 2019 Mar 21;93(7):
pubmed: 30651366
Vaccine. 2012 Jan 11;30(3):597-606
pubmed: 22120195
Biomacromolecules. 2005 May-Jun;6(3):1375-9
pubmed: 15877355
J Transl Med. 2012 Jan 05;10:4
pubmed: 22221900
Nat Med. 2013 Jul;19(7):869-78
pubmed: 23836237
Nat Med. 2005 Apr;11(4 Suppl):S63-8
pubmed: 15812492
Clin Exp Vaccine Res. 2015 Jan;4(1):23-45
pubmed: 25648619
Biomacromolecules. 2006 Jan;7(1):394-9
pubmed: 16398541
Biomacromolecules. 2004 Sep-Oct;5(5):1999-2006
pubmed: 15360316
Science. 2015 Aug 21;349(6250):790-1
pubmed: 26293940
J Immunol Methods. 2018 Oct;461:63-72
pubmed: 29894744
Expert Rev Vaccines. 2016 Dec;15(12):1535-1544
pubmed: 27267297
BMJ. 2000 Aug 12;321(7258):424
pubmed: 10938051
PLoS One. 2013 Apr 08;8(4):e61287
pubmed: 23593453
J Microbiol Immunol Infect. 2017 Apr;50(2):160-166
pubmed: 26066544
Nat Med. 2013 Dec;19(12):1597-608
pubmed: 24309663
J Med Microbiol. 2012 Jul;61(Pt 7):927-934
pubmed: 22174375
Vet Immunol Immunopathol. 1995 Sep;48(1-2):123-38
pubmed: 8533308
Curr Drug Deliv. 2010 Jan;7(1):13-20
pubmed: 19863483
J Infect Dis. 2016 Jun 15;213(12):1946-54
pubmed: 26908741
Biomacromolecules. 2016 Nov 14;17(11):3732-3742
pubmed: 27748602
Mol Pharm. 2017 Aug 7;14(8):2815-2823
pubmed: 28686452
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12288-93
pubmed: 25136130